Updated Jul 16, 2026
Link Matthew has filed 1 SEC Form 4 filing across 1 company in the last 90 days — selling. Lifetime open-market sales: $510K.
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2025-07-02 | SGHT | Sight Sciences, Inc. | S — Open-market sale | 4.9K | $4.10 | $20K |
| 2024-10-21 | SGHT | Sight Sciences, Inc. | S — Open-market sale | 21.8K | $5.61 | $122K |
| 2024-10-21 | SGHT | Sight Sciences, Inc. | S — Open-market sale | 20.5K | $5.98 | $122K |
| 2024-10-18 | SGHT | Sight Sciences, Inc. | S — Open-market sale | 21.0K | $5.84 | $122K |
| 2024-10-18 | SGHT | Sight Sciences, Inc. | S — Open-market sale | 20.7K | $5.91 | $122K |
Link Matthew is a corporate insider — currently tracked as Director of FibroBiologics, Inc. (FBLG). InsiderAlpha tracks every SEC Form 4 filing in real time.
1 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 0 open-market purchases () and 5 open-market sales ($510K) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Link Matthew profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.